← Leaderboards
Kenneth Walsh
Tufts University Boston
$48,396,088
Attributed
$52,824,848
Total exposure
34
Grants
24
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $4.5M · FY2005–25$5M$3.8M$2.5M$1.3M$0
'05
'06
'07
'08
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23
'24
'25
Funding mix
By agency
NIH$72,023,565 · 35
By mechanism
R01$38,212,567 · 22
P01$28,417,578 · 9
R37$4,036,624 · 1
R21$1,356,796 · 3
Top collaborators
- Noyan Gokce10 shared
- Fabio A Recchia4 shared
- Christopher R Defilippi2 shared
Others in their field
Top investigators on “Cells”
- Lawrence Corey · Fred Hutchinson Cancer Center$536,344,731
- Barton F Haynes · Duke University$457,457,619
- David Heimbrook · Leidos Biomedical Research, Inc.$454,789,509
- Glenda E Gray · Wits Health Consortium (Pty), Ltd$299,104,942
- Dennis R. Burton · Scripps Research Institute$278,781,854
- Mary M Horowitz · Medical College Of Wisconsin$237,383,608
Research focus
CellsSignal TransductionPhenotypeMolecularLinkCardiovascular DiseasesMediatingProteinsMouse ModelResponseRegulationBaseInflammatoryInflammationFunctional DisorderTissuesMetabolicBlood VesselsObesityHeart FailureCardiacAdipose TissueHeartGenes
Grant awards (155)
Mosaic Loss of the Y Chromosome in Cardiac Amyloidosis$568,246
R01 · FY2025 · AG · contact PI
Mosaic loss of Y chromosome in blood and heart failure$398,708
R01 · FY2025 · AG · contact PI
Mosaic Loss of the Y Chromosome in Cardiac Amyloidosis$599,966
R01 · FY2024 · AG · contact PI
Mosaic loss of Y chromosome in blood and heart failure$421,355
R01 · FY2024 · AG · contact PI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity$403,750
R01 · FY2024 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$596,762
R01 · FY2023 · HL
Mosaic loss of Y chromosome in blood and heart failure$451,082
R01 · FY2023 · AG · contact PI
Mosaic loss of Y chromosome in blood and heart failure$403,750
R01 · FY2023 · AG · contact PI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity$403,750
R01 · FY2023 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$596,762
R01 · FY2022 · HL
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity$534,760
R01 · FY2022 · HL · contact PI
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease$485,033
R01 · FY2022 · HL · contact PI
Mosaic loss of Y chromosome in blood and heart failure$448,852
R01 · FY2022 · AG · contact PI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity$403,750
R01 · FY2022 · HL · contact PI
Clonal hematopoiesis and severity of COVID-19 disease$120,235
R21 · FY2022 · AG · contact PI
Wnt signaling control of vascular phenotype in obesity$636,513
R01 · FY2021 · HL
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity$534,760
R01 · FY2021 · HL · contact PI
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease$485,033
R01 · FY2021 · HL · contact PI
Mosaic loss of Y chromosome in blood and heart failure$430,616
R01 · FY2021 · AG · contact PI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity$403,750
R01 · FY2021 · HL · contact PI
Clonal hematopoiesis and severity of COVID-19 disease$336,624
R21 · FY2021 · AG · contact PI
Somatic TET2 mutations in cardiac remodeling$638,816
R01 · FY2020 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$635,154
R01 · FY2020 · HL
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity$534,760
R01 · FY2020 · HL · contact PI
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease$485,033
R01 · FY2020 · HL · contact PI
Role of therapy-related clonal hematopoiesis in anthracycline-induced cardiotoxicity$403,750
R01 · FY2020 · HL · contact PI
Follistatin-like protein 1 in cardiac and systemic metabolism$695,637
R01 · FY2019 · HL
Somatic TET2 mutations in cardiac remodeling$638,816
R01 · FY2019 · HL · contact PI
Wnt signaling control of vascular phenotype in obesity$612,625
R01 · FY2019 · HL
Clonal hematopoiesis and accelerated metabolic dysfunction in obesity$534,760
R01 · FY2019 · HL · contact PI
Inflammatory Wnt signaling in ischemic myocardium$532,633
R01 · FY2019 · HL · contact PI
Hematopoietic stem cell mutations and ischemic cardio-metabolic disease$485,033
R01 · FY2019 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2019 · HL
Inflammatory Pathways in Aortic Aneurysms$474,774
R01 · FY2019 · HL · contact PI
Follistatin-like protein 1 in cardiac and systemic metabolism$713,913
R01 · FY2018 · HL
Somatic TET2 mutations in cardiac remodeling$638,816
R01 · FY2018 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2018 · HL
Inflammatory Pathways in Aortic Aneurysms$464,925
R01 · FY2018 · HL · contact PI
Inflammatory Wnt signaling in ischemic myocardium$300,000
R01 · FY2018 · HL · contact PI
Inflammatory Wnt signaling in ischemic myocardium$231,692
R01 · FY2018 · HL · contact PI
Inflammatory Pathways in Aortic Aneurysms$9,490
R01 · FY2018 · HL · contact PI
Follistatin-like protein 1 in cardiac and systemic metabolism$742,374
R01 · FY2017 · HL
Somatic TET2 mutations in cardiac remodeling$536,880
R01 · FY2017 · HL · contact PI
Inflammatory Wnt signaling in ischemic myocardium$531,019
R01 · FY2017 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2017 · HL
Inflammatory Pathways in Aortic Aneurysms$473,336
R01 · FY2017 · HL · contact PI
Myokine Control of Hepatic Steatosis$205,625
R21 · FY2017 · AG · contact PI
Somatic TET2 mutations in cardiac remodeling$100,000
R01 · FY2017 · HL · contact PI
Follistatin-like protein 1 in cardiac and systemic metabolism$778,602
R01 · FY2016 · HL
Inflammatory Wnt signaling in ischemic myocardium$529,512
R01 · FY2016 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2016 · HL
Inflammatory Pathways in Aortic Aneurysms$472,760
R01 · FY2016 · HL · contact PI
Paracrine Regulation of Heart Failure$409,250
R01 · FY2016 · HL · contact PI
Mitochondrial dynamics and cardiac remodeling$409,250
R01 · FY2016 · HL · contact PI
Myokine Control of Hepatic Steatosis$246,750
R21 · FY2016 · AG · contact PI
Metabolic Control of Endothelias Cell Phenotype$1,973,677
P01 · FY2015 · HL · contact PI
ADIPOSE TISSUE INFLAMMATION & VASCULARITY$525,671
P01 · FY2015 · HL · contact PI
Anti-Angiogenic Mechanisms in Human Obesity$478,464
R01 · FY2015 · HL
Mitochondrial dynamics and cardiac remodeling$403,111
R01 · FY2015 · HL · contact PI
Paracrine Regulation of Heart Failure$403,111
R01 · FY2015 · HL · contact PI
HIGH-THROUGHPUT GENE EXPRESSION$216,789
P01 · FY2015 · HL · contact PI
ADMINISTRATIVE CORE$164,084
P01 · FY2015 · HL · contact PI
Metabolic Control of Endothelias Cell Phenotype$1,964,008
P01 · FY2014 · HL · contact PI
ADIPOSE TISSUE INFLAMMATION & VASCULARITY$523,007
P01 · FY2014 · HL · contact PI
Paracrine Regulation of Heart Failure$401,065
R01 · FY2014 · HL · contact PI
Mitochondrial dynamics and cardiac remodeling$401,065
R01 · FY2014 · HL · contact PI
Muscle loss and metabolic dysfunction associated with aging$322,564
R01 · FY2014 · AG · contact PI
HIGH-THROUGHPUT GENE EXPRESSION$215,687
P01 · FY2014 · HL · contact PI
ADMINISTRATIVE CORE$163,249
P01 · FY2014 · HL · contact PI
Metabolic Control of Endothelias Cell Phenotype$1,908,101
P01 · FY2013 · HL · contact PI
ADIPOSE TISSUE INFLAMMATION & VASCULARITY$508,062
P01 · FY2013 · HL · contact PI
Paracrine Regulation of Heart Failure$389,606
R01 · FY2013 · HL · contact PI
Mitochondrial dynamics and cardiac remodeling$389,606
R01 · FY2013 · HL · contact PI
Muscle loss and metabolic dysfunction associated with aging$304,668
R01 · FY2013 · AG · contact PI
LKB1 Signaling and the Endothelial Cell Response to Acute Ischemia$285,490
P01 · FY2013 · HL · contact PI
HIGH-THROUGHPUT GENE EXPRESSION$209,525
P01 · FY2013 · HL · contact PI
ADMINISTRATIVE CORE$158,585
P01 · FY2013 · HL · contact PI
Metabolic Control of Endothelias Cell Phenotype$15,006
P01 · FY2013 · HL · contact PI
Metabolic Control of Endothelias Cell Phenotype$2,004,124
P01 · FY2012 · HL · contact PI
ADIPOSE TISSUE INFLAMMATION & VASCULARITY$532,415
P01 · FY2012 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$408,731
R37 · FY2012 · AG · contact PI
Muscle loss and metabolic dysfunction associated with aging$322,170
R01 · FY2012 · AG · contact PI
LKB1 Signaling and the Endothelial Cell Response to Acute Ischemia$299,885
P01 · FY2012 · HL · contact PI
HIGH-THROUGHPUT GENE EXPRESSION$219,570
P01 · FY2012 · HL · contact PI
ADMINISTRATIVE CORE$166,190
P01 · FY2012 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$5,000
R37 · FY2012 · AG · contact PI
Metabolic Control of Endothelias Cell Phenotype$2,032,997
P01 · FY2011 · HL · contact PI
ADIPOSE TISSUE INFLAMMATION & VASCULARITY$532,751
P01 · FY2011 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$408,728
R37 · FY2011 · AG · contact PI
Muscle loss and metabolic dysfunction associated with aging$321,349
R01 · FY2011 · AG · contact PI
LKB1 Signaling and the Endothelial Cell Response to Acute Ischemia$299,885
P01 · FY2011 · HL · contact PI
ADMINISTRATIVE CORE$166,296
P01 · FY2011 · HL · contact PI
Mitochondrial Fusion and Cardiac Function$122,562
R21 · FY2011 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$412,857
R37 · FY2010 · AG · contact PI
LKB1 Signaling and the Endothelial Cell Response to Acute Ischemia$385,752
P01 · FY2010 · HL · contact PI
Adipose Tissue Inflammation and Vascularity$342,766
R01 · FY2010 · DK · contact PI
Muscle loss and metabolic dysfunction associated with aging$333,125
R01 · FY2010 · AG · contact PI
Mitochondrial Fusion and Cardiac Function$325,000
R21 · FY2010 · HL · contact PI
Endothelial Redox State & Phenotype in Health & Disease$2,403,760
P01 · FY2009 · HL · contact PI
Redox regulation in Endothelial Progenitor Cells$460,619
P01 · FY2009 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$404,880
R37 · FY2009 · AG · contact PI
LKB1 Signaling and the Endothelial Cell Response to Acute Ischemia$402,793
P01 · FY2009 · HL · contact PI
Molecular Control of Myo/Angiogenesis$392,041
R01 · FY2009 · HL · contact PI
SIGNALING PATHWAYS IN HEART FAILURE$382,828
R01 · FY2009 · HL · contact PI
Mechanisms of Angiogenesis$50,447
R01 · FY2009 · HL · contact PI
Endothelial Redox State & Phenotype in Health & Disease$2,298,142
P01 · FY2008 · HL · contact PI
Redox regulation in Endothelial Progenitor Cells$440,339
P01 · FY2008 · HL · contact PI
Mechanisms of Angiogenesis$406,250
R01 · FY2008 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$393,088
R37 · FY2008 · AG · contact PI
Molecular Control of Myo/Angiogenesis$392,041
R01 · FY2008 · HL · contact PI
SIGNALING PATHWAYS IN HEART FAILURE$382,828
R01 · FY2008 · HL · contact PI
Endothelial Redox State & Phenotype in Health & Disease$2,302,976
P01 · FY2007 · HL · contact PI
Redox regulation in Endothelial Progenitor Cells$439,204
P01 · FY2007 · HL · contact PI
Molecular Control of Myo/Angiogenesis$392,041
R01 · FY2007 · HL · contact PI
SIGNALING PATHWAYS IN HEART FAILURE$382,828
R01 · FY2007 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$382,828
R37 · FY2007 · AG · contact PI
Endothelial Redox State & Phenotype in Health & Disease$2,295,926
P01 · FY2006 · HL · contact PI
Redox regulation in Endothelial Progenitor Cells$415,636
P01 · FY2006 · HL · contact PI
Molecular Control of Myo/Angiogenesis$403,750
R01 · FY2006 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$394,262
R37 · FY2006 · AG · contact PI
SIGNALING PATHWAYS IN HEART FAILURE$394,262
R01 · FY2006 · HL · contact PI
REGULATION OF VESSEL WALL APOPTOSIS$5,000
R37 · FY2006 · AG · contact PI
Redox regulation in Endothelial Progenitor Cells$403,870
P01 · FY2005 · HL
REGULATION OF VESSEL WALL APOPTOSIS$403,750
R37 · FY2005 · AG
SIGNALING PATHWAYS IN HEART FAILURE$403,750
R01 · FY2005 · HL
MOLECULAR CONTROL OF MYOGENESIS$270,988
R01 · FY2005 · AR
PATHOLOGY OF MITOSIS IN VASCULAR SMOOTH MUSCLE$244,500
R01 · FY2005 · AG
Molecular studies of heart failure$228,075
P01 · FY2005 · HL
Core--Plasmid$228,075
P01 · FY2005 · HL
REGULATION OF VESSEL WALL APOPTOSIS$5,000
R37 · FY2005 · AG
REGULATION OF VESSEL WALL APOPTOSIS$403,750
R37 · FY2004 · AG
MOLECULAR CONTROL OF MYOGENESIS$270,988
R01 · FY2004 · AR
PATHOLOGY OF MITOSIS IN VASCULAR SMOOTH MUSCLE$244,500
R01 · FY2004 · AG
REGULATION OF VESSEL WALL APOPTOSIS$5,000
R37 · FY2004 · AG
REGULATION OF VESSEL WALL APOPTOSIS$403,750
R37 · FY2003 · AG
MOLECULAR CONTROL OF MYOGENESIS$270,988
R01 · FY2003 · AR
PATHOLOGY OF MITOSIS IN VASCULAR SMOOTH MUSCLE$244,500
R01 · FY2003 · AG
REGULATION OF VESSEL WALL APOPTOSIS$343,672
R01 · FY2002 · AG
MOLECULAR CONTROL OF MYOGENESIS$270,988
R01 · FY2002 · AR
PATHOLOGY OF MITOSIS IN VASCULAR SMOOTH MUSCLE$244,500
R01 · FY2002 · AG
Molecular studies of heart failure$209,266
P01 · FY2002 · HL
Core--Plasmid$209,266
P01 · FY2002 · HL
Skeletal muscle survival during differentiation$0
P01 · FY2002 · HD
REGULATION OF VESSEL WALL APOPTOSIS$350,039
R01 · FY2001 · AG
PATHOLOGY OF MITOSIS IN VASCULAR SMOOTH MUSCLE$249,750
R01 · FY2001 · AG
MOLECULAR CONTROL OF MYOGENESIS$230,250
R01 · FY2001 · AR
TRANSCRIPTIONAL CONTROL OF CARDIOVASCULAR PATHOLOGY$205,466
R01 · FY2001 · HL
TRANSCRIPTIONAL CONTROL OF CARDIOVASCULAR PATHOLOGY$129,463
R01 · FY2001 · HL
MOLECULAR CONTROL OF MYOGENESIS$46,556
R01 · FY2001 · AR
Molecular studies of heart failure$0
P01 · FY2001 · HL
Core--Plasmid$0
P01 · FY2001 · HL
Skeletal muscle survival during differentiation$0
P01 · FY2001 · HD
REGULATION OF VESSEL WALL APOPTOSIS$339,844
R01 · FY2000 · AG
TRANSCRIPTIONAL CONTROL OF CARDIOVASCULAR PATHOLOGY$325,175
R01 · FY2000 · HL
Skeletal muscle survival during differentiation$208,825
P01 · FY2000 · HD